Last Posted: Oct 18, 2018
- ClinVar database of global familial hypercholesterolemia-associated DNA variants.
Iacocca Michael A et al. Human mutation 2018 Nov 39(11) 1631-1640 - Contributions of Public Health in Reducing the Population Burden of Familial Hypercholesterolemia: Challenges and Opportunities
MJ Khoury et al, CDC Blog Post, October 17, 2018 - Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project.
Ibarretxe Daiana et al. Atherosclerosis 2018 Oct 278210-216 - Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia.
Paquette Martine et al. Journal of clinical lipidology 2018 Sep - Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe.
Harada-Shiba Mariko et al. Journal of atherosclerosis and thrombosis 2018 May 25(5) 422-429 - Familial Hypercholesterolemia in Children and Adolescents: Diagnosis and Treatment.
Maliachova Olga et al. Current pharmaceutical design 2018 Oct - Perspectives from a state genetics coordinator: Public health’s role in addressing familial hypercholesterolemia (FH) in the United States
Deb Lochner Doyle, Blog Post, October 17, 2018 - Prevalence, Identification, and Scouting for Familial Hypercholesterolaemia including Registries.
Florentin Matilda et al. Current pharmaceutical design 2018 Oct - Role of PCSK9 inhibitors in high risk patients with dyslipidemia: Focus on familial hypercholesterolemia.
Papademetriou Vasilios et al. Current pharmaceutical design 2018 Oct - New horizons in the pathogenesis, pathophysiology and treatment of familial hypercholesterolaemia.
Viigimaa Margus et al. Current pharmaceutical design 2018 Oct
.png)
No hay comentarios:
Publicar un comentario